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In recent years, genome-wide association studies (GWAS) have identified hundreds of loci and thou-
sands of single-nucleotide polymorphisms (SNPs) associated with type 2 diabetes mellitus (T2DM) 
and obesity traits [such as body mass index (BMI) and waist–hip ratio (WHR)] in the human popula-
tion (1–4). The vast majority of these SNPs are in non-coding regions of the genome and distal to 
promoters, suggesting they act through gene regulation which makes their functional interpretation 
challenging (5). Collectively, comparing the epigenetic landscape between mouse and human has 
established new pathways involved in obesity and diabetes, and in fact, inter-species conservation 
has successfully been used as criteria in finding functional and disease-relevant elements (6–8). By 
contrast, genome-wide comparative analysis of the mouse and human epigenome across tissues has 
highlighted the presence of cis-regulatory divergence (9, 10). New mouse engineering approaches 
together with bioinformatics dissection of trait-associated regions, for example, epigenetic modifica-
tions and genome interactions hold great promise to fully understand the underlying mechanisms 
of human disease-associated non-coding variants in T2DM and obesity.
THE COnTEXT-SpECiFiC nATURE OF HUMAn GWA SiGnALS  
in HUMAn
Over 80% of loci identified by GWAS are in intergenic and intronic regions and many of these genetic 
risk regions are enriched for histone modifications (5), suggesting they act as regulatory elements 
which appear to function in a highly cell-selective manner. Due to the tissue specificity as well as 
the developmental and epigenetic complexity of gene regulation, functional approaches require the 
study of the relevant tissue and cell type as well as genetic and bioinformatics approaches that reliably 
assess the regulatory role of non-coding variants (7, 11, 12). Ongoing progress in high-throughput 
sequencing and the development of new experimental tools are greatly advancing our capacity to 
study chromatin biology and genome function. In particular, ChIP-seq allows identification of 
transcription factor binding sites and chromatin states; chromosome conformation capture-based 
techniques (including 3C, 4C, 5C, CaptureC, and HiC) allow the study of chromatin interactions; 
and DNase hypersensitivity or ATAC-seq can identify accessible chromatin (13–16). Additionally, 
tools like HaploReg (17), Enlight (18), RegulomeDB (19), and The Islet Regulome Browser (11) are 
emerging that allow the integration of GWAS results with genetic and epigenetic annotations that 
can be used to dissect the gene regulatory networks that underpin genomic association signals.
By integrating the information gained from functional genomics efforts such as the ENCODE 
(5) and Roadmap Epigenomics projects (20) together with expression quantitative trait loci (eQTL) 
results and functional studies, it becomes increasingly clear that adipose tissue is one of several key 
effectors of genetic risk loci for T2DM and obesity trait associations, particularly for WHR signals 
(2, 7, 21, 22). However, there is currently still a lack of comprehensive maps linking distal elements 
that harbor disease-associated variants with their target genes in relevant tissues and developmental 
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stages. Furthermore, extensive fine-mapping of risk associations 
is crucial in order to narrow down the association signal to the 
likely causative variants which can then be functionally investi-
gated (23). This has resulted in many studies being performed 
assuming that the closest gene to a given disease-associated 
signal is the causative one. Traditionally, target genes based on 
proximity to a signal were selected to model in the mouse using 
global or tissue-specific gene knockout or overexpression alleles 
to characterize gene function (24). However, with this approach, 
many target genes for GWA signals have potentially been over-
looked, for example, in the case of the BMI-associated variants 
in Fto (25, 26). An additional level of complexity comes with the 
possibility for an association signal—that usually harbors dozens 
of SNPs—to potentially contain a number of disease-causing 
variants that might act in different tissues and/or at different 
times, affecting different genes. For example, there is currently 
evidence for intronic FTO risk variants to alter the expression 
of nearby genes in both adipose tissue and brain. An eQTL in 
human cerebellum links re9930509 to altered IRX3 expression 
(25), rs1421085 has very convincingly been shown to be located 
within an enhancer for IRX3 and IRX5 in adipocyte precursors (7, 
26) and rs1421085 and rs8050136 have been proposed to selec-
tively alter FTO and RPGRIP1L expression in human-induced 
pluripotent stem cell-derived neurons (27). Therefore, mouse 
models which could help pinpoint variants, target genes, and 
relevant tissues would prove invaluable in the mechanistic dis-
section of human disease-associated sequence variants. However, 
whether it is possible to use the mouse for modeling regulatory 
variants (which is essential to capture the relevant spatiotemporal 
effects) will depend on the functional conservation of the regula-
tory circuitry of a given signal in human and mouse.
COnSERVATiOn BETWEEn HUMAn  
AnD MOUSE
It is estimated that our last common ancestor with the mouse was 
about 90 million years ago (28). At this point, many of the core 
physiological regulatory mechanisms had evolved, for example, 
mouse and human share the same basic mechanisms for control-
ling food intake via leptin and hypothalamic anorexigenic and 
orexigeneic neurons, and similarly insulin and glucagon are core 
effectors in glucose homeostasis. However, there have clearly 
been many evolutionary changes over this long period of time. 
At the level of the genome, chromosome number and organiza-
tion have changed, although it is striking how large tracts of 
DNA have conserved their order of genes and show high coding 
sequence conservation (29). Thus, if we wish to use the mouse 
as model of human metabolic disease we can rely on much of 
the core conservation of ancient metabolic pathways and their 
regulation but cannot ignore the fact of their continued evolution 
that adapts and changes these mechanisms for the survival of 
two very different organisms. The mouse ENCODE Consortium 
reported that comparative gene expression data from human and 
mouse reveals that some sets of genes tend to cluster more by 
species than by tissue and vice versa (29). More recently, it has 
been suggested that gene clustering by tissue rather than species 
is much stronger than originally thought (30). Interestingly, 
single-cell sequencing of human and mouse pancreatic alpha and 
beta cells showed good cross-species correlation of transcrip-
tomes although with some important species differences (31). 
Finally, Breschi et al. (32) describe how transcriptomes show a 
continuum of variation from species dominated clustering to 
organ dominated clustering. Importantly, for modeling GWA 
signals in other species, genes that varied little between species 
(and are more organ-specific) are more likely to overlap with 
human risk variants (32).
EpiGEnOMiC COnSERVATiOn BETWEEn 
HUMAn AnD MOUSE—inSiGHTS FROM 
THE MOUSE EnCODE COnSORTiUM
Some of the other key findings of ENCODE in the mouse 
genome were that human and mouse trans-regulatory networks 
(transcription factor networks) are considerably more conserved 
than the cis-regulatory landscape, which in fact accounts for the 
majority of regulatory plasticity between human and mouse (28, 
29). At the same time, the degree of divergence of regulatory ele-
ments varies widely between different types of elements that are 
active in different tissue contexts (9, 28). The Mouse ENCODE 
Consortium (29) demonstrated that 79.3% of mouse candidate 
enhancers (predicted by patterns of histone modifications) 
and 66.7% of transcription factor binding sites have sequence 
orthologs in humans. Further, 61.5% of tested candidate 
mouse-specific enhancers also show enhancer activity in human 
embryonic stem cells in a reporter assay (29), suggesting a degree 
of functional conservation between human and mouse gene 
regulation. Based on this level of conservation, it is intriguing 
to ask the question whether mouse chromatin states could be 
used to identify potential sites for functional characterization in 
mouse for human GWAS hits. Mapping 4,265 SNPs from human 
GWAS studies onto the mouse genome using 15 mouse samples 
revealed that human GWAS hits are associated with specific 
chromatin states in relevant mouse tissues (29). For example, 
in mouse kidney, H3K4me1 is enriched in specific GWAS hits 
associated with urate levels and metabolites. For mouse liver-
specific H3K36me3, GWAS hits related to HDL cholesterol and 
triglyceride levels are enriched. Together, 55% of mapped SNPs 
overlapped with at least one histone mark in mouse (29). These 
results suggest that histone modification marks can be used to 
inform about human risk variants and for the identification of 
candidate functional sequences for characterization of human 
GWAS hits in mouse.
Furthermore, SNPs with high regulatory potential are 
enriched in conserved transcription factor binding sites (19). 
Cheng et  al. (33) show that conserved sequences occupied by 
orthologous transcription factors in human and mouse are 
enriched for GWAS variants. When investigating whether this 
is true for individual phenotypes, they found that SNPs associ-
ated with type I diabetes and several other traits are significantly 
enriched in conserved transcription factor binding sites, with 13 
out of 20 type 1 diabetes SNPs being in conserved binding sites. 
By contrast, all of the SNPs associated with pulmonary function 
FiGURE 1 | Functional validation of variants in human and mouse. An integrative approach for the generation of meaningful and informative mouse models of 
human Genome-Wide Association Study (GWAS) signals. Deciphering the underpinnings of an association signal in the human context is essential. For mechanistic 
studies in vivo, a human-to-mouse epigenomic comparison can guide the choice of a relevant mouse model, e.g., in the case of low or insufficient functional 
conservation of a regulatory site (or the lack of data sets that can determine the latter) a classical tissue-specific target gene manipulation can prove valuable; in the 
case of a high functional conservation (based on genomics and bioinformatics dissection of the loci), a model that selectively manipulates the regulatory region can 
in principle be useful. Comparing the human–mouse epigenome can be expected to become increasingly powerful with the improvement of quality as well as the 
comprehensiveness of genomic data sets and tools. The translational utility will depend on the mouse model chosen and the information gained can feedback and 
help interpret human GWAS signals.
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were found to be human-specific, suggesting that besides GWAS 
SNPs generally being enriched in conserved regulatory elements, 
that this enrichment is dependent on the trait (33). Whether this 
is the case for T2DM and obesity traits association is yet to be 
investigated. With continuous efforts and the increase in available 
mouse genome data sets, it will become possible to draw conclu-
sions about the human–mouse conservation of transcription fac-
tor occupancy and enrichment of GWAS SNPs in adipose tissue. 
Indeed, on a cellular level, a systematic comparison between the 
human and mouse epigenome during adipocyte development and 
in different fat depots is largely missing, and Mouse ENCODE 
has currently only limited adipose tissue datasets that could be 
matched to human. Though, Mikkelsen et  al. (34) generated a 
comparative analysis of chromatin state maps together with gene 
expression profiles from human adipose tissue and mouse 3T3-
L1 at four time points during differentiation. They showed that 
although a significant amount of open chromatin in orthologous 
regions were shared between the two models (15–30%), most of 
them were species-specific. While we are not proposing that this 
affected the key findings of this study, it is worth pointing out that 
comparing a mouse cell line and primary human tissue-derived 
pre-adipocytes with their accompanying ontogenetic differences 
can potentially hinder the interpretation when using these data 
sets for dissecting specific GWAS loci with the aim to establish 
relevant functional sites.
Taken together, although the cis-regulatory landscape has 
substantially diverged between human and mouse on a global 
level, human trait-associated SNPs are enriched in sites that 
are conserved between the two species for the majority of traits 
investigated.
THE pOTEnTiAL FOR nEW STRATEGiES 
in MOUSE MODEL EnGinEERinG
With our current knowledge of the context-specificity of gene 
regulation and consequently the many layers of complexity 
of most GWAS signals, it becomes increasingly clear that it is 
necessary to study and understand the underlying regulatory 
network in the relevant human tissue (Figure  1). In the past, 
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a successful approach to studying the function of individual 
candidate genes in vivo has been achieved by generating global 
knockout and overexpression models (24). However, these 
models do not resemble the tissue-specific nature of alterations 
in regulatory elements. Tissue-specific target gene manipula-
tion using CRE drivers can be a powerful tool to overcome this 
problem. However, another challenge comes with the current lack 
of reliable pre-adipocyte-specific CRE lines that can be used to 
assess the tissue-specific effect of identified target genes in cases 
of pre-adipocyte-specific signals. Recent advances in genome 
engineering, namely CRISPR/Cas9, opened the opportunity to 
conveniently alter any regulatory sequence of interest (35). In 
other words, it is now possible to genome edit transcription fac-
tor binding sites and enhancer elements in the mouse which in 
principle has the potential to create mouse models of human risk 
variants that (i) are cell type-specific; (ii) alter all target genes; 
(iii) alter target genes at the relevant level and direction; and (iv) 
alter target genes at the relevant time of development (Figure 1).
COnCLUSiOn AnD FUTURE DiRECTiOnS
The majority of human genetic variants associated with common 
metabolic disease traits are located within distal regulatory ele-
ments. With our current knowledge of gene regulation and the 
context-specificity of the signal, it is necessary to understand the 
signal in human. Identifying targets and context is crucial in engi-
neering a relevant mouse model. A comprehensive human-to-
mouse epigenomic comparison can be informative about human 
risk variants. Although intriguingly, whether manipulation of 
regulatory elements will become a tool to dissect human obesity/
T2DM risk variants in the mouse will depend on the functional 
conservation of a given signal. This is yet to be established and 
offers an exciting avenue to explore.
GLOSSARY
ATAC-seq—assay for transposase-accessible chromatin followed 
by high-throughput sequencing. This technique allows the iden-
tification of open chromatin.
BMI—body mass index. A measure of body weight that takes 
account of an individual’s size and calculated by dividing body 
weight by height squared.
ChIP-seq—chromatin immunoprecipitation followed by 
high-throughput sequencing. This technique allows the identi-
fication of DNA fragments that are bound by a specific antibody.
Cis-regulatory—non-coding DNA sequences in or near a 
gene required for its spatiotemporal expression that characteristi-
cally contain transcription factor binding sites.
CRE—Cre recombinase recognizes DNA sequences known 
as LoxP sites and when a pair of sites is provided in the same 
orientation this leads to deletion of the intervening sequence. In 
this way, a segment of DNA such as a key exon (said to be floxed) 
can be deleted resulting in, for example, a null mutation. This can 
be done in vivo by gene editing to place LoxP sites in the required 
location and then crossing animals that carry this modification 
to Cre recombinase strains, which then results in recombination. 
The expression of Cre recombinase can be driven by a promoter 
of choice either as a transgene or knocked into an endogenous 
gene promoter. Thus, the recombinase can be expressed in specific 
tissues as required allowing cell- or tissue-specific recombination, 
i.e., for the generation of a conditional knockout.
Epigenome—a network of chemical compounds (for example, 
DNA methylation or histone modifications) surrounding DNA 
that modify the genome without altering the DNA sequence 
itself. These modifying elements play a role in determining which 
genes are active in a particular cell at a particular time.
eQTL—expression quantitative trait loci are genomic loci that 
contribute to variation in the expression levels of mRNAs. For 
example, in individuals in a population inheriting SNP allele A, 
the expression of gene Y is found to be quantitatively increased 
or decreased on average relative to the other SNP alleles inherited 
across the population assayed. This is a correlated trait rather than 
a direct functional link between a SNP and the expression of a 
gene. Further, any particular SNP marks a haplotype (a linked 
co-inherited group) of SNPs and as such represents a locus.
GWAS—Genome-Wide Association Study.
iPSC—induced pluripotent stem cell.
SNP—single-nucleotide polymorphism.
T2DM—type 2 diabetes mellitus.
Transcriptome—the entire mRNA expressed from the genes 
of a cell.
Trans-regulatory—in the context of transcriptional regula-
tion, a trans-acting element is usually a DNA sequence that con-
tains a gene. This gene encodes for a protein (or other molecules 
such as microRNA) that will regulate another target gene.
WHR—waist-to-hip ratio.
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